Form 4: Protagonist CFO Sells Shares for Tax Obligations

Protagonist Therapeutics CFO Asif Ali sold 8,588 shares of common stock at $82.48 per share to cover tax withholding obligations.

Summary

• Asif Ali, Chief Financial Officer of Protagonist Therapeutics, Inc. (PTGX), reported a sale of common stock.
• The transaction involved the disposition of 8,588 shares of PTGX common stock.
• The shares were sold at a price of $82.48 per share.
• The sale occurred on January 20, 2026.
• The purpose of the sale was to cover tax withholding obligations incurred upon the settlement of restricted stock units.
• Following this transaction, Asif Ali beneficially owns 78,077 shares of Protagonist Therapeutics common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary sale of shares to cover tax obligations, which is a common occurrence for executives receiving equity compensation. It does not indicate a positive or negative view on the company's future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction, common across all industries, where executives sell shares to cover tax liabilities arising from the vesting of equity awards. It typically does not reflect a change in the company's fundamental business or industry trends.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary sale for tax purposes and not indicative of a change in management's confidence or company fundamentals.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The transaction reported is a routine, non-discretionary sale by a Chief Financial Officer to cover tax withholding obligations associated with the vesting of restricted stock units. Such sales are common and typically pre-scheduled, not reflecting a change in the executive's outlook on the company's performance or fundamental value. Therefore, this filing alone does not provide a basis for changing an investment position, warranting a 'hold' recommendation.

Keywords

Protagonist Therapeutics, PTGX, Asif Ali, CFO, Insider Sale, Form 4, Stock Transaction, Tax Withholding, Restricted Stock Units